Elanco Animal Health has patented a method using lubabegron to reduce ammonia and carbon dioxide emissions from bovines, increasing hot carcass weight. This innovation offers a solution to environmental concerns in livestock farming. GlobalData’s report on Elanco Animal Health gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Elanco Animal Health Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Elanco Animal Health, NSAID cancer drugs was a key innovation area identified from patents. Elanco Animal Health's grant share as of January 2024 was 47%. Grant share is based on the ratio of number of grants to total number of patents.

A recently granted patent (Publication Number: US11864567B2) discloses a method for reducing gas emissions, specifically ammonia and carbon dioxide, from bovines by administering lubabegron or its physiologically acceptable salt. The method aims to increase the hot carcass weight of the bovine, potentially benefiting the livestock industry by improving efficiency and reducing environmental impact.

In addition to lubabegron, the patent claims the administration of other active ingredients such as monensin, tylosin, and melengestrol, or their physiologically acceptable salts, to achieve the desired reduction in gas emissions. The method specifies that the reduction can be measured per pound of the bovine's weight while alive or per pound of its hot carcass weight. By focusing on bovines, particularly cows, this method presents a targeted approach to addressing environmental concerns related to livestock farming while potentially enhancing the economic outcomes for producers through increased carcass weight.

To know more about GlobalData’s detailed insights on Elanco Animal Health, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies